Unicycive Therapeutics Inc. Revenue 2022–2023
Unicycive Therapeutics Inc. annual/quarterly revenue history and growth rate from 2022 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Unicycive Therapeutics Inc. revenue for the quarter ending March 31, 2023 was 675000.
- Unicycive Therapeutics Inc. annual revenue for 2023 was 675000, a 29.02% decrease from 2022.
- Unicycive Therapeutics Inc. annual revenue for 2022 was 951000.
Unicycive Therapeutics Inc. (UNCY) — Frequently Asked Questions
Unicycive Therapeutics Inc. (UNCY) is a publicly traded US company. It has a market capitalization of $189M. In fiscal 2023 it reported revenue of $675,000 and net income of -$31M. Explore UNCY's stock price, financial statements, earnings history, margins and key ratios below.
What is Unicycive Therapeutics Inc.'s market cap?
Unicycive Therapeutics Inc. (UNCY) has a market capitalization of $189M.
What is the UNCY stock price?
UNCY trades at $7.69 (+5.78% on the day).
How much revenue does Unicycive Therapeutics Inc. make?
Unicycive Therapeutics Inc. reported revenue of $675,000 in fiscal 2023.
Is UNCY profitable?
In fiscal 2023, Unicycive Therapeutics Inc. reported net income of -$31M.